Interactive effect of combined exposure to active and passive smoking on cardiovascular system

Recent Patents on Cardiovascular Drug Discovery

Volumn 6, Issue 1, 2011, Pages 61-69

  Leone, Aurelio ^a,b  

^a Department of Internal Medicine City Hospital Massa ^*  (Italy)

^b The Royal Society for Public Health   (United Kingdom)

Author keywords

Active smoking; Cardiovascular damage; Interaction; Passive smoking

Indexed keywords

ANGIOTENSIN II; CARBON MONOXIDE; CARBOXYHEMOGLOBIN; ENDOTHELIN 1; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NICOTINE; PROSTACYCLIN;

ACTIVE SMOKING; ANGINA PECTORIS; ARTERY WALL; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE; BLOOD VISCOSITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DISEASE COURSE; ENDOTHELIAL DYSFUNCTION; ENVIRONMENTAL EXPOSURE; GENE INTERACTION; GENETIC VARIABILITY; HEART MUSCLE; HEART RATE; HEART REINFARCTION; HUMAN; ISCHEMIC HEART DISEASE; LIPID METABOLISM; METABOLIC DISORDER; OXIDATIVE STRESS; PASSIVE SMOKING; PRIORITY JOURNAL; SMOKING; THROMBOCYTE AGGREGATION;

ANIMALS; ARTERIES; CARDIOVASCULAR DISEASES; HEART; HUMANS; MYOCARDIUM; RISK ASSESSMENT; RISK FACTORS; SMOKING; TOBACCO SMOKE POLLUTION;

EID: 79551670969     PISSN: 15748901     EISSN: None     Source Type: Journal    
DOI: 10.2174/157489011794578437     Document Type: Article

References (111)

1. Leone A. Cardiovascular damage from smoking: A fact or belief? Int J Cardiol 1993; 38: 113-117.
2. Sherman CB. Health effects of cigarette smoking. Clin Chest Med 1991; 12(4): 643-658.
3. Leone A. The heart: A target organ for cigarette smoking. J Smok- Relat Dis 1992; 3: 197-201.
4. US Department of Health, Education, and Welfare: The health consequences of smoking: A report of the Surgeon General. Cardiovascular disease. Rockville, MD: US Department of Health and Human Services, Public Health Service Office of Smoking and Health. DHHS Publication NO (PHS) 84-50204, 1983.
5. Leone A. Cigarette smoking and health of the heart. J R Soc Health 1995; 115: 354-835.
6. Flouris AD, Metsios GS, Jamurtas AZ, Koutedakis Y. Cardiorespiratory and immune response to physical activity following exposure to a typical smoking environment. Heart 2010; 96(11): 860-S864.
7. McBride PE. The health consequences of smoking. Cardiovascular diseases. Med Clin North Am 1992; 76: 333-353.
8. Aronow WS. Effect of passive smoking on angina pectoris. N Engl J Med 1978; 299: 21-24.
9. Sparrow D, Dawber TR, Colton T. The influence of cigarette smoking on prognosis after a first myocardial infarction. J Chronic Dis 1978; 31: 425-432.
10. Leone A, Bertanelli F, Mori L, Fabiano P, Bertoncini G. Ventricular arrhythmias by passive smoking in patients with preexisting myocardial infarction. J Am Coll Cardiol 1992; 3: 256 (A).
11. Wilhelmsson C, Vedin JA, Elmfeldt D, Tibblin G, Wilhelmsen L. Smoking and myocardial infarction. Lancet 1975; 1: 415-420.
12. Auerbach O, Carter HW, Garfinkel L, Hammond EC. Cigarette smoking and coronary heart disease, a macroscopic and microscopic study. Chest 1976; 70: 697-705.
13. Reid DD, Hamilton PJS, McCartney P, Rose G. Smoking and other risk factors in coronary heart disease in British civil servants. Lancet 1976; 11: 979-984.
14. Glantz SA, Parmley WW. Passive smoking and heart disease. JAMA 1995; 273: 1047-1053.
15. Wells AJ. Passive smoking as a cause of heart disease. J Am Coll Cardiol 1994; 24: 546-554.
16. Meinert CL, Forman S, Jacobs DR, Stamler J. Cigarette smoking as a risk factor in men with a prior history of myocardial infarction. J Chronic Dis 1979; 32: 415-425.
17. Glantz SA, Parmley WW. Passive smoking and heart disease: Epidemiology, physiology, and biochemistry. Circulation 1991; 83: 1-12.
18. Baer L, Radichevich I. Cigarette smoking in hypertensive patients. Blood pressure and endocrine responses. Am J Med 1985; 78: 564-568.
19. Celermajer DS, Adams MR, Clarkson P, Robinson J, McCredie R, Donald A, et al. Passive smoking and impaired endothelium dependent arterial dilatation in healthy young adults. N Engl J Med 1996; 334: 150-154.
20. Leone A, Lopez M. Oral contraception, ovarian disorders and tobacco in myocardial infarction of woman. Pathologica 1986; 78: 237-242.
21. Pojola S, Siltanen P, Romo M. Five-year survival of 728 patients after myocardial infarction. Br Heart J 1980; 43: 176-183.
22. Leone A. Relationship between cigarette smoking and other coronary risk factors in atherosclerosis: Risk of cardiovascular disease and preventive measures. Curr Pharm Des 2003; 9: 2417-2423.
23. Byrd JC. Environmental tobacco smoke. Medical and legal issues. Med Clin North Am 1992; 76: 377-397.
24. Peto R, Lopez AD, Boreham J, Thun M, Heath C. Mortality from smoking in developed countries: 1950-2000. Oxford: Oxford Univ Press 1994.
25. Wald NJ, Hackshaw AK. Cigarette smoking: An epidemiological overview. Br Med Bull 1996; 52: 3-11.
26. Leone A, Bertanelli F, Mori L, Fabiano P, Battaglia A. Features of ischaemic cardiac pathology resulting from cigarette smoking. J Smok-Relat Dis 1994; 5: 109-114.
27. Health or Smoking. Follow-up Report of the Royal College of Physicians. Pitman Publishing: London 1983.
28. Astrup P. The arterial wall in atherogenesis. In: Cavallero Ed. Atherogenesis. Padua, Piccin Medical Books 1965: 77-92.
29. Leone A. Biochemical markers of cardiovascular damage from tobacco smoke. Curr Pharm Des 2005; 11: 2199-2208.
30. Leone A, Landini L Jr, Biadi O, Balbarini A. Smoking and cardiovascular system: Cellular features of the damage. Curr Pharm Des 2008; 14: 1771-1777.
31. Doyle JT, Dawber TR, Kannel WB. The relationship of cigarette smoking to coronary heart disease: The second report of the combined experience of the Albany NY, and Framingham, Mass, studies. JAMA 1964; 190: 886-890.
32. Strong JP, Richards ML, McGill HC Jr. On the association of cigarette smoking with coronary and aortic atherosclerosis. J Atheroscler Res 1969; 10: 303-317.
33. Eliot RS, Baroldi G, Leone A. Necropsy studies in myocardial infarction with minimal or no coronary luminal reduction due to atherosclerosis. Circulation 1974; 49: 1127-1131.
34. Cryer PE, Haymond MW, Santiago JV, Shah SD. Norepinephrine and epinephrine release and adrenergic mediation of smokingassociated hemodynamic and metabolic events. N Engl J Med 1976; 295: 573-577.
35. Grassi G, Seravalle G, Calhoun DA, Bolla GB, Giannattasio C, Marabini M, et al. Mechanisms responsible for sympathetic activation by cigarette smoking in humans. Circulation 1994; 90: 248-253.
36. Groppelli A, Giorgi DM, Omboni S, Parati G, Mancia G. Persistent blood pressure increase induced by heavy smoking. J Hypertens 1992; 10: 495-499.
37. Schievelbein H, Richter F. The influence of passive smoking in the cardiovascular system. Prev Med 1984; 13: 626-644.
38. Pope CA 3rd, Eatough DJ, Gold DR, Pang Y, Nielsen KR, Nath P, et al. Acute exposure to environmental tobacco smoke and heart rate variability. Environ Health Perspect 2001; 109: 711-716.
39. Leone A. Five markers capable to identify passive smoking exposure associated with endothelial dysfunction in healthy individuals. Curr Hypertens Rev 2008; 4: 183-189.
40. Mahmud A, Feely G. Effect of smoking on arterial stiffness and pulse pressure amplification. Hypertension 2003; 41:183-187.
41. Masala G, Bendinelli B, Versari D, Saieva C, Ceroti M, Santagiuliana F, et al. Anthropometric and dietary determinants of blood pressure in over 7000 Mediterranean women: The European Prospective Investigation into Cancer and Nutrition-Florence cohort. J Hypertens 2008; 26: 2112-2120.
42. Ross RK, Paganini-Hill A, Mack TM, Arthur M, Henderson BE. Menopausal oestrogen therapy and protection from death from ischaemic heart disease. Lancet 1981; 1: 858-860.
43. Hurn PD, Brass ML. Estrogen and stroke: A balanced analysis. Stroke 2003; 34: 338-341.
44. Higashi Y, Sanada M, Sasaki S, Nakagawa K, Goto C, Matsuura H, et al. Effect of estrogen replacement therapy on endothelial function in peripheral resistance arteries in normotensive and hypertensive postmenopausal women. Hypertension 2001; 37: 651-657.
45. Primatesta P, Falaschetti E, Gupta S, Marmot MG, Poulter NR. Association between smoking and blood pressure: Evidence from the health survey for England. Hypertension 2001; 37: 187-193.
46. Minami J, Ishimitsu T, Matsuoka H. Effects of smoking cessation on blood pressure and heart rate variability in habitual smokers. Hypertension 1999; 33: 586-590.
47. Lee DH, Ha MH, Kim JR, Jacobs DR, Jr. Effects of smoking cessation on changes in blood pressure and incidence of hypertension: A 4-year follow-up study. Hypertension 2001; 37:194-198.
48. Bonita R, Duncan J, Truelsen T, Jackson RT, Beaglehole R. Passive smoking as well as active smoking increase the risk of acute stroke. Tob Control 1999; 8: 156-160.
49. Leone A. Passive smoking exposure and cardiovascular health. Handbook of Cardiovascular Research. In: Brataas J, Nanstveit V, Eds. Nova Science Publishers, Inc.: New York 2009; 81-111.
50. Leone A, Mori L, Bertanelli F, Fabiano P, Filippelli M. Indoor passive smoking: Its effect on cardiac performance. Int J Cardiol 1991; 8: 247-252.
51. Garland C, Barret-Connor E, Suarez L, Criqui MH, Wingard DL. Effects of passive smoking on ischemic coronary heart disease mortality of non-smokers: A prospective study. Am J Epidemiol 1985; 121: 645-650.
52. Hirayama T. Passive smoking: A new target of epidemiology. Tokai J Exp Clin Med 1985; 10: 287-293.
53. Svendsen KH, Kuller LH, Martin MJ, Ockene JK. Effects of passive smoking in the Multiple Risk Factor Intervention Trial. Am J Epidemiol 1987; 126: 783-795.
54. Helsing KJ, Sandler DP, Comstock GW, Chee E. Heart disease mortality in nonsmokers living with smokers. Am J Epidemiol 1988; 127: 915-922.
55. He Y. Women's passive smoking and coronary heart disease. G Hua Yu Fang I Husueh Tsa Chih 1989; 23: 19-22.
56. Hole DJ, Gillis CR, Copra C, Hawthorne VM. Passive smoking and cardiorespiratory health in a general population in the west of Scotland. Br Med J 1989; 299: 423-427.
57. Dobson AJ, Alexander HM, Heller RF, Lloyd DM. Passive smoking and the risk of heart attack of coronary death. Med J Aust 1991; 154: 793-797.
58. Lee PN, Chamberlain J, Alderson M. Relatinship of passive smoking to risk of lung cancer and other smoking-associated diseases. Br J Cancer 1986; 54: 97-105.
59. Humble C, Croft J, Gerber A, Casper M, Hames CG, Tyroler HA. Passive smoking and 20-year cardiovascular disease mortality among non-smoking wives, Evans County, Georgia. Am J Public Health 1990; 80: 599-601.
60. Deedwania PC. Endothelium: A new target for cardiovascular therapeutics. J Am Coll Cardiol 2000; 35: 65-70.
61. Davis JW, Shelton L, Watanabe IS, Arnold J. Passive smoking affects endothelium and platelets. Arch Intern Med 1989; 149: 386-389.
62. Sumida H, Watanabe H, Kugiyama K, Ohgushi M, Matsumura T, Yasue H. Does passive smoking impair endothelium-dependent coronary artery dilation in women? J Am Coll Cardiol 1998; 31: 811-815.
63. Giannini D, Leone A, DiBisceglie D, Nuti M, Strata G, Buttitta F, et al. The effects of acute passive smoke exposure on endotheliumdependent brachial artery dilation in healthy individuals. Angiology 2007; 58: 211-217.
64. Penn A, Chen LC, Snyder CA. Inhalation of steady-state side stream smoke from cigarettes promotes arteriosclerotic plaque development. Circulation 1994; 90: 1363-1367.
65. Kjeldsen K, Thomsen H, Astrup P. Effects of carbon monoxide on myocardium: Ultrastructural changes in rabbits after moderate, chronic exposure. Circ Res 1974; 34: 339-348.
66. Thomsen H, Kjeldsen K. Threshold limit for carbon monoxide induced myocardial damage. Arch Environ Health 1974; 29: 73-78.
67. Lough J. Cardiomyopathy produced by cigarette smoke. Arch Pathol Lab Med 1978; 102: 377-380.
68. Fuster V, Cheseboro H, Frye RL, Elveback LR. Platelet survival and the development of coronary artery disease in the young adult: Effects of cigarette smoking, strong family history and medical therapy. Circulation 1981; 63: 546-551.
69. Milionis HJ, Elisaf MS, Mikhailidis DP. The effects of lipid regulating therapy on haemostatic parameters. Curr Pharm Des 2003; 9: 2425-2443.
70. Church DF, Pryor WA. Free-radical chemistry of cigarette smoke and its toxicological implications. Environ Health Perspect 1985; 64: 111-126.
71. Ferrari R, Ceconi C, Curello S, Cargoni A, Alfeiri O, Pardini A, et al. Oxygen free radicals and myocardial damage: protective role of thiol-containing agents. Am J Med 1991; 91: 95S-105S.
72. Leone A. Metabolic Disorders. Passive smoking and cardiovascular pathology - mechanisms and physiopathological basis of damage. In: Leone A, Ed. Nova Science Publishers, Inc.: New York 2007; 97-118.
73. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li R, et al. Isolation of putative endothelial progenitor cells for angiogenesis. Science 1997; 275: 964-967.
74. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, et al. Circulating endothelial progenitor cells, vascular function and cardiovascular risk. N Engl J Med 2003; 348: 593-600.
75. Walter DH, Ritting K, Bahlmann FH, Kirchmair R, Silver KM, Murayama T, et al. Statin therapy accelerates reendothelization: A novel effect involving mobilization and incorporation of bonemarrow derived endothelial progenitor cells. Circulation 2002; 105: 3017-3024.
76. Murohara T, Ikeda H, Duan J, Shintani S, Ken-ichiro S, Eguchi H, et al. Transplanted cord blood-derived endothelial progenitor cells augment postnatal neovascularization. J Clin Invest 2000; 105: 1527-1536.
77. Wang XX, Zhu JH, Chen JZ, Shang YP. Effects of nicotine on the number and activity of circulating endothelial progenitor cells. J Clin Pharmacol 2004; 44: 881-889.
78. Armani C, Landini L Jr, Leone A. Molecular and biochemical changes of the cardiovascular system due to smoking exposure. Curr Pharm Des 2009; 15: 1038-53.
79. Armani C, Landini L, Leone A. Interactive effect of cigarette smoking and gene variants for predisposing to cardiovascular disease. Curr Pharm Des 2010; 23: 2531-258.
80. Howard G, Burke GL, Szklo M, Tell GS, Eckfeldt J, Evans G, et al. Active and passive smoking are associated with increased carotid wall thickness. Arch Intern Med 1994; 154: 1277-1282.
81. Stefanidis C, Vlachopoulos C, Tsiamis E. Unfavourable effects of passive smoking in aortic function in men. Ann Intern Med 1998; 128: 426-434.
82. Moreyra AE, Lacy CR, Wilson AC, Kumar A, Kostis JB. Arterial blood nicotine concentration and coronary vasoconstrictive effect of low-nicotine cigarette smoking. Am Heart J 1992; 124: 392-397.
83. Quillen JE, Rossen JD, Oskarsson HJ, Minor RL Jr, Lopez AG, Winniford MD, et al. Acute effect of cigarette smoking on the coronary circulation constriction of epicardial and resistance vessels. J Am Coll Cardiol 1993; 22: 642-647.
84. Mikhailidis DP, Barradas MA, Nystrom ML, Jeremy JY. Cigarette smoking increases with blood cells aggregation in whole blood. J R Soc Med 1993; 86(11): 680-681.
85. Zhu BQ, Sun YP, Sievers RE, Isenberg WM, Glantz SA, Parmley WW. Passive smoking increases experimental atherosclerosis in cholesterol fed rabbits. J Am Coll Cardiol 1993; 21: 225-232.
86. Benowitz NL. Nicotine and coronary heart disease. Trends Cardiovasc Med 1991; 1: 315-321.
87. Imaizumi TA, Satoh K, Yoshida H, Kawamura Y, Hiramoto M, Takamatsu S. Effect of cigarette smoking on the levels of plateletactivating factor-like lipid(s) in plasma lipoproteins. Atheroscler 1991; 87: 47-55.
88. Stone MC, Thorpe JM. Plasma-fibrinogen - a major coronary risk factor. J R Coll Gen Pract 1985; 35: 565-569.
89. Miyaura S, Eguchi H, Johnston JM. Effect of a cigarette smoke extract on the metabolism of the proinflammatory autacoid, platelet-activating factor. Circ Res 1992; 70: 341-347.
90. Adams KF, Koch G, Catterjee B, Goldstein GM, O'Neil JJ, Bromberg PA, et al. Acute elevation of blood carboxyhemoglobin to 6% impairs exercise performance and aggravates symptoms in patients with ischemic heart disease. J Am Coll Cardiol 1988; 12(4): 900-909.
91. Sheps DS, Herbst MC, Hinderliter AL, Adams KF, Ekelund LG, O'Neil JJ, et al. Production of arrhythmias by elevated carboxyhemoglobin in patients with coronary artery disease. Ann Intern Med 1990; 113(5): 343-351.
92. Ezzati M, Lopez AD. Estimates of global mortality attributable to smoking in 2000. Lancet 2003; 362: 847-852.
93. He Y, Lam TH, Jiang B, Wang J, Sai X, Fan L, et al. Combined effects of tobacco smoke exposure and metabolic syndrome on cardiovascular risk in older residents of China. J Am Coll Cardiol 2009; 53: 363-367.
94. Trevisan M, Liu J, Bahsas FB, Menotti A. Syndrome X and mortalità: A population-based study. Risk factor and life expectancy research group. Am J Epidemiol 1998; 148: 958-966.
95. Lakka HM, Laaksonen DE, Lakka TA. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288: 2709-2716.
96. Taylor BV, Oudit GY, Kalman PG, Liu P. Clinical and pathophysiological effects of active and passive smoking on the cardiovascular system. Can J Cardiol 1998; 14(9): 1129-1139.
97. Varnava A. Coronary artery remodelling. Heart 1998; 79: 109-110.
98. Leone A. Cigarette smoking and cardiovascular damage: Analytic review of the subject. Singapore Med J 1994; 35: 492-494.
99. Folts JD, Bonebrake FC. The effects of cigarette smoke and nicotine on platelet thrombus formation in stenosed dog coronary arteries: Inhibition with phentolamine. Circulation 1982; 65: 465-470.
100. Leone A, Landini L, Leone A. What is tobacco smoke? Sociocultural dimensions of the association with cardiovascular risk. Curr Pharm Des 2010; 16: 2510-2517.
101. Yancey, Jr D.D. System and methods for cultivating, harvesting and processing biomass. WO2010141559 (2010).
102. Ross, C. Analysis of heart rate variability data in animals for health conditions assessment. US20080004539 (2008).
103. Rossing M., Kieval, R.S., Erwin, E., Pedersen, B.D., Braginisky, V. Applications of heart rate variability analysis in electrotherapyaffecting autonomic nervous system response. US20080009917 (2008).
104. Riftine, A. Method for quantitative assessment of the autonomic nervous system based on heart rate variability analysis. US20090005696 (2008).
105. Beise, R.D. Method for evaluating heart rate variability. US20080058662 (2008).
106. Bolea, S.L., Kieval, R.S., Persson, B.J., Serdar, D.J., Keith, P.T., Irwin, E.D., Rossing, M.A. Assessing autonomic activity using baroreflex analysis. US20080171923 (2008).
107. Vinitsky, A.R. Reversing autonomic nervous system dysfunction by potentiating methylation. US20080045448 (2008).
108. Rousso, B., Dickman, D., Nagler, M., Vallabhajosula, S. Multidimensional image reconstruction and analysis for expert-system diagnosis. US20080033291 (2008).
109. Flouris AD, Vardavas CI, Metsios GS, Tsatsakis AM, Koutedakis Y. Biological evidence for the acute health effects of secondhand smoke exposure. Am J Physiol Lung Cell Moll Physiol 2010; 298(1): L3-L12.
110. Flouris AD, Metsios GS, Jamurtas AZ, Koutedakis Y. Sexual dimorphism in the acute effects of secondhand smoke on thyroid hormone secretion, inflammatory markers and vascular function. Am J Physiol Endocrinol Metab 2008; 294(2): E456-462.
111. Metsios GS, Flouris AD, Jamurtas AZ, Carrillo AE, Kouretas D, Germenis AE, et al. A brief exposure to moderate passive smoke increases metabolism and thyroid hormone secretion. J Clin Endocrinol Metab 2007; 92(1): 208-211.